New stock news: Youcare Pharmaceutical Group(688658.SH) filed documents to Hong Kong Stock Exchange.

According to the disclosure of the Hong Kong Stock Exchange on December 29, Youcare Pharmaceutical Group Limited (referred to as: Youcare Pharmaceutical Group (688658.SH)) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with CITIC SEC as its exclusive sponsor. The prospectus disclosed that Youcare Pharmaceutical Group is a biopharmaceutical company focusing on research, development, production, and commercialization of four types of therapies: oligonucleotides, messenger ribonucleic acid (mRNA) vaccines, peptides, and traditional Chinese medicine innovative drugs. The company utilizes a combination of commercialized product portfolio, cross-modal R&D technology platform and capabilities, production systems certified with Good Manufacturing Practice (GMP), and a nationwide commercialization network to advance candidate products in major therapeutic areas with high unmet needs and long-term growth potential through differentiated innovative pipelines.